Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis

T. Koudriavtseva, A. J. Thompson, M. Fiorelli, C. Gasperini, S. Bastianello, A. Bozzao, A. Paolillo, A. Pisani, S. Galgani, C. Pozzilli

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The aim of the study was to evaluate the predictive power of baseline gadolinium (Gd) enhanced MRI in relation to subsequent clinical and MRI activity. Sixty eight patients with clinically definite relapsing-remitting multiple sclerosis had a baseline Gd enhanced MRI and were followed up clinically and by monthly Gd enhanced MRI for six months. The occurrence of relapses during the follow up period was predicted by the presence of at least one enhancing lesion on the baseline MRI (P <0.05). The number and volume of enhancing lesions at baseline were significantly associated with both enhancing lesions observed during the follow up period (P <0.0001) and the accumulation of abnormality on T2 weighted images (P <0.0001). Moreover, the presence of three or more enhancing lesions at baseline scan was consistently associated with the development of permanent abnormalities on T2 weighted images six months later. The study suggests that the number and volume of Gd enhancing lesions at a single examination are strong short term predictors of subsequent clinical and MRI activity.

Original languageEnglish
Pages (from-to)285-287
Number of pages3
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume62
Issue number3
Publication statusPublished - 1997

Fingerprint

Relapsing-Remitting Multiple Sclerosis
Gadolinium
Recurrence

Keywords

  • Enhanced MRI
  • Predictivity
  • Relapsing-remitting multiple sclerosis

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Psychiatry and Mental health

Cite this

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. / Koudriavtseva, T.; Thompson, A. J.; Fiorelli, M.; Gasperini, C.; Bastianello, S.; Bozzao, A.; Paolillo, A.; Pisani, A.; Galgani, S.; Pozzilli, C.

In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 62, No. 3, 1997, p. 285-287.

Research output: Contribution to journalArticle

Koudriavtseva, T, Thompson, AJ, Fiorelli, M, Gasperini, C, Bastianello, S, Bozzao, A, Paolillo, A, Pisani, A, Galgani, S & Pozzilli, C 1997, 'Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, vol. 62, no. 3, pp. 285-287.
Koudriavtseva, T. ; Thompson, A. J. ; Fiorelli, M. ; Gasperini, C. ; Bastianello, S. ; Bozzao, A. ; Paolillo, A. ; Pisani, A. ; Galgani, S. ; Pozzilli, C. / Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. In: Journal of Neurology, Neurosurgery and Psychiatry. 1997 ; Vol. 62, No. 3. pp. 285-287.
@article{d512a278fe8e42ba9d58e4d4f8541b04,
title = "Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis",
abstract = "The aim of the study was to evaluate the predictive power of baseline gadolinium (Gd) enhanced MRI in relation to subsequent clinical and MRI activity. Sixty eight patients with clinically definite relapsing-remitting multiple sclerosis had a baseline Gd enhanced MRI and were followed up clinically and by monthly Gd enhanced MRI for six months. The occurrence of relapses during the follow up period was predicted by the presence of at least one enhancing lesion on the baseline MRI (P <0.05). The number and volume of enhancing lesions at baseline were significantly associated with both enhancing lesions observed during the follow up period (P <0.0001) and the accumulation of abnormality on T2 weighted images (P <0.0001). Moreover, the presence of three or more enhancing lesions at baseline scan was consistently associated with the development of permanent abnormalities on T2 weighted images six months later. The study suggests that the number and volume of Gd enhancing lesions at a single examination are strong short term predictors of subsequent clinical and MRI activity.",
keywords = "Enhanced MRI, Predictivity, Relapsing-remitting multiple sclerosis",
author = "T. Koudriavtseva and Thompson, {A. J.} and M. Fiorelli and C. Gasperini and S. Bastianello and A. Bozzao and A. Paolillo and A. Pisani and S. Galgani and C. Pozzilli",
year = "1997",
language = "English",
volume = "62",
pages = "285--287",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis

AU - Koudriavtseva, T.

AU - Thompson, A. J.

AU - Fiorelli, M.

AU - Gasperini, C.

AU - Bastianello, S.

AU - Bozzao, A.

AU - Paolillo, A.

AU - Pisani, A.

AU - Galgani, S.

AU - Pozzilli, C.

PY - 1997

Y1 - 1997

N2 - The aim of the study was to evaluate the predictive power of baseline gadolinium (Gd) enhanced MRI in relation to subsequent clinical and MRI activity. Sixty eight patients with clinically definite relapsing-remitting multiple sclerosis had a baseline Gd enhanced MRI and were followed up clinically and by monthly Gd enhanced MRI for six months. The occurrence of relapses during the follow up period was predicted by the presence of at least one enhancing lesion on the baseline MRI (P <0.05). The number and volume of enhancing lesions at baseline were significantly associated with both enhancing lesions observed during the follow up period (P <0.0001) and the accumulation of abnormality on T2 weighted images (P <0.0001). Moreover, the presence of three or more enhancing lesions at baseline scan was consistently associated with the development of permanent abnormalities on T2 weighted images six months later. The study suggests that the number and volume of Gd enhancing lesions at a single examination are strong short term predictors of subsequent clinical and MRI activity.

AB - The aim of the study was to evaluate the predictive power of baseline gadolinium (Gd) enhanced MRI in relation to subsequent clinical and MRI activity. Sixty eight patients with clinically definite relapsing-remitting multiple sclerosis had a baseline Gd enhanced MRI and were followed up clinically and by monthly Gd enhanced MRI for six months. The occurrence of relapses during the follow up period was predicted by the presence of at least one enhancing lesion on the baseline MRI (P <0.05). The number and volume of enhancing lesions at baseline were significantly associated with both enhancing lesions observed during the follow up period (P <0.0001) and the accumulation of abnormality on T2 weighted images (P <0.0001). Moreover, the presence of three or more enhancing lesions at baseline scan was consistently associated with the development of permanent abnormalities on T2 weighted images six months later. The study suggests that the number and volume of Gd enhancing lesions at a single examination are strong short term predictors of subsequent clinical and MRI activity.

KW - Enhanced MRI

KW - Predictivity

KW - Relapsing-remitting multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0030935805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030935805&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 285

EP - 287

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 3

ER -